Virtu Financial »

Bioxcel Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $176k 60k 2.96
2021-12-31 $250k 12k 20.35

More positions owned by Virtu Financial

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Technology (XLK)
Meta Platforms Cl A (META)
Direxion Shs Etf Tr Drx S P500bull (SPXL)
Direxion Shs Etf Tr 20yr Tres Bear (TMV)
Vanguard Index Fds S P 500 Etf Shs (VOO)
Select Sector Spdr Tr Financial (XLF)
Synopsys (SNPS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Altria (MO)
Hess (HES)
Pfizer (PFE)
News Corp Cl A (NWSA)
Invesco Currencyshares Cdn D CDN DLR SHS (FXC)

View all positions for Virtu Financial

Top funds holding Bioxcel Therapeutics

Vanguard Group
Beacon Pointe Advisors
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Arete Wealth Advisors
Bank of America Corporation
Bank Of Montreal
Millennium Management
Wells Fargo & Company
Virtu Financial
Squarepoint Ops
Tocqueville Asset Management
UBS Group
D. E. Shaw & Co

View all funds holding Bioxcel Therapeutics